The hypotensive effect of the ruthenium complex [Ru(terpy)(bdq)NO]3+ is higher in male than in female spontaneously hypertensive rats (SHR)

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 387, Issue 11, 2014, Pages 1045-1051

  Potje, Simone R ^a,b   Hildebrand, Mariana C ^a   Munhoz, Felipe C ^a,b   Troiano, Jéssica A ^a,b   Pereira, Ariana A F ^a,b   Nakamune, Ana Claúdia M S ^a,b   Da Silva, Roberto S ^b   Bendhack, Lusiane M ^b   Antoniali, Cristina ^a,b  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Blood pressure; Gender; Hypotensive effect; Nitric oxide donor; Oxidative stress; SHR

Indexed keywords

(RU(NH.NHQ)(TERPY)NO)3; ACETOPHENONE DERIVATIVE; AMINE OXIDE; APOCYNIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONOR; ORGANOMETALLIC COMPOUND; SPIN LABELING; TEMPOL;

ANIMAL; BLOOD PRESSURE; DRUG EFFECTS; FEMALE; HYPERTENSION; MALE; METABOLISM; OXIDATIVE STRESS; PATHOPHYSIOLOGY; RAT; SEX DIFFERENCE; SPIN LABELING; SPONTANEOUSLY HYPERTENSIVE RAT; WISTAR RAT;

ACETOPHENONES; ANIMALS; BLOOD PRESSURE; CYCLIC N-OXIDES; FEMALE; HYPERTENSION; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONORS; ORGANOMETALLIC COMPOUNDS; OXIDATIVE STRESS; RATS; RATS, INBRED SHR; RATS, WISTAR; SEX FACTORS; SPIN LABELS;

EID: 84939895858     PISSN: 00281298     EISSN: 14321912     Source Type: Journal    
DOI: 10.1007/s00210-014-1020-2     Document Type: Article

References (30)

1. Bonaventura D, Oliveira FS, Togniolo V, Tedesco AC, da Silva RS, Bendhack LM (2004) A macrocyclic nitrosyl ruthenium complex is a NO donor that induces rat aorta relaxation. Nitric Oxide 10:83-91. doi: 10.1016/j.niox.2004.03.004
2. Bubb KJ, Khambata RS, Ahluwalia A (2012) Sexual dimorphism in rodent models of hypertension and atherosclerosis. Br J Pharmacol 167:298-312. doi: 10.1111/j.1476-5381.2012.02036.x
3. Buege JA, Aust SD (1978) Microsomal lipid peroxidation. Methods Enzymol 52:302-310
4. Chen YF, Meng QM (1991) Sexual dimorphism of blood pressure in spontaneously hypertensive rats is androgen dependent. Life Sci 48:85-96. doi: 10.1016/0024-3205(91)90428-E
5. Dantas APV, Tostes RCA, Fortes ZB, Costa SG, Nigro D, Carvalho MHC (2002) In vivo evidence for antioxidant potential of estrogen in microvessels of female spontaneously hypertensive rats. Hypertens 39:405-411. doi: 10.1161/hy0202.102993
6. Dantas APV, Franco MCP, Silva-Antonialli MM, Tostes RCA, Fortes ZB, Nigro D, Carvalho MHC (2004) Gender differences in superoxide generation in microvessels of hypertensive rats: role of NAD(P)H-oxidase. Cardiovasc Res 61:22-29. doi: 10.1016/j.cardiores.2003.10.010
7. de Barros BF, Toledo JC, Franco DW, Tfouni E, Krieger MH (2002) A new inorganic vasodilator, trans-[Ru(NO)(NH3)4(POEt)3](PF6)3: hypotensive effect of endothelium-dependent and independent vasodilators in different hypertensive animals models. Nitric Oxide 7:50-56. doi: 10.1016/S1089-8603(02)00007-1
8. de Gaitani CM, de Melo MC, Lunardi CN, Oliveira FS, da Silva RS, Bendhack LM (2009) Hypotensive effect of the nitrosyl ruthenium complex nitric oxide donor in renal hypertensive rats. Nitric Oxide 20:195-199. doi: 10.1016/j.niox.2008.12.002
9. de Lima RG, Sauaia MG, Bonaventura D, Tedesco AC, Bendhack LM, da Silva RS (2006) Influence of ancillary ligand L in the nitric oxide photorelease by the [Ru(L)(terpy)NO]3+ complex and its vasodilator activity based on visible light irradiation. Inorg Chim Acta 359:2543-2549. doi: 10.1016/j.ica.2006.02.020
10. Fortepiani LA, Reckelhoff JF (2005a) Increasing oxidative stress with molsidomine increases blood pressure in genetically hypertensive rats but not normotensive controls. Am J Physiol Regul Integr Comp Physiol 289:R763-R770. doi: 10.1152/ajpregu.00526.2004
11. Fortepiani LA, Reckelhoff JF (2005b) Role of oxidative stress in the sex differences in blood pressure in spontaneously hypertensive rats. J Hypertens 23:801-805. doi: 10.1097/01.hjh.0000163149.05083.13
12. Ganten U, Schroder G, Witt M, Zimmerman F, Ganten D, Stock G (1989) Sexual dimorphism of blood pressure in spontaneously hypertensive rats: effects of anti-androgen treatment. J Hypertens 7:721-726. doi: 10.1097/00004872-198909000-00005
13. Gilbert JS, Nijland MJ (2008) Sex differences in the developmental origins of hypertension and cardiorenal disease. Am J Physiol Regul Integr Comp Physiol 295(6):R1941-R1952. doi: 10.1152/ajpregu.90724.2008
14. Iams SG, McMurtry JP, Wexler BC (1979) Aldosterone, deoxycorticosterone, and prolactin changes during lifespan of chronically and spontaneously hypertensive rats. Endocrinology 104:1357-1363. doi: 10.1210/endo-104-5-1357
15. Kauser K, Rubanyi GM (1995) Gender difference in endothelial dysfunction in the aorta of spontaneously hypertensive rats. Hypertension 25:517-523. doi: 10.1161/01.HYP.25.4.517
16. Khalil RA (2005) Sex hormones as potential modulators of vascular function in hypertension. Hypertension 46:249-254. doi: 10.1161/01.HYP.0000172945.06681.a4
17. Knot HJ, Lounsbury KM, Brayden JE, Nelson MT (1999) Gender differences in coronary artery diameter reflect changes in both endothelial Ca2+ and ecNOS activity. Am J Physiol 276:H961-H969
18. Lowry OH, Rosebrough NJ, Farr AL, Randal RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
19. Lunardi CN, Vercesi JA, da Silva RS, Bendhack LM (2007) Vasorelaxation induced by the new nitric oxide donor cis-[Ru(Cl)(bpy)(2)(NO)](PF(6)) is due to activation of K(Ca) by a cGMP-dependent pathway. Vasc Pharmacol 47:139-144. doi: 10.1016/j.vph.2007.05.003
20. MarIn J, Rodrigues-Martinez A (1997) Role of vascular nitric oxide in physiological and pathological conditions. Pharmacol Ther 75:111-134. doi: 10.1016/S0163-7258(97)00051-X
21. Masubuchi Y, Kumai T, Uematsu A, Komoriyama K, Hirai M (1982) Gonadectomy-induced reduction in blood pressure in adult spontaneously hypertensive rats. Acta Endocrinol (Copenh) 101:154-160. doi: 10.1530/acta.0.1010154
22. McIntyre M, Hamilton CA, Rees DD, Reid JL, Dominiczak AF (1997) Sex differences in the abundance of endothelial nitric oxide in a model of genetic hypertension. Hypertension 30:1517-1524. doi: 10.1161/01.HYP.30.6.1517
23. Monies GS, Luque EH (1988) Effects of ovarian steroids on vaginal smears in the rat. Acta Anat 133:192-199. doi: 10.1159/000146639
24. Munhoz FC, Potje SR, Pereira AC, Daruge MC, da Silva RS, Bendhack LM, Antoniali C (2012) Hypotensive and vasorelaxing effects of the new NO-donor [Ru(terpy)(bdq)NO(+)](3+) in spontaneously hypertensive rats. Nitric Oxide 26:111-117. doi: 10.1016/j.niox.2011.12.008
25. Nakazono K, Watanabe N, Matsuno K, Sasaki J, Sato T, Inoue M (1991) Does superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci U S A 88:10045-10048. doi: 10.1073/pnas.88.22.10045
26. Rodrigues GJ, Pereira AC, Vercesi JA, Lima RG, da Silva RS, Bendhack LM (2012) Long lasting hypotensive effect in renal hypertensive rats induced by nitric oxide released from a ruthenium complex. J Cardiovasc Pharmacol 60:193-198. doi: 10.1097/FJC.0b013e31825bacc4
27. Romero M, Caniffi C, Bouchet G, Elesgaray R, Laughlin MM, Tomat A, Arranz C, Costa MA (2013). Sex differences in the beneficial cardiac effects of chronic treatment with atrial natriuretic peptide in spontaneously hypertensive rats. 12;8(8):e71992. doi: 10.1371/journal.pone.0071992.
28. Sartori-Valinotti JC, Iliescu R, Yanes LL, Dorsett-Martin W, Reckelhoff JF (2008) Sex differences in the pressor response to angiotensin II when the endogenous renin-angiotensin system is blocked. Hypertension 51:1170-1176. doi: 10.1161/HYPERTENSIONAHA.107.106922
29. Sato M, Yanagisawa H, Nojima Y, Tamura J, Wada O (2002) Zn deficiency aggravates hypertension in spontaneously hypertensive rats: possible role of Cu/Zn-superoxide dismutase. Clin Exp Hypertens 24:355-370
30. Sullivan JC, Sasser JM, Pollock JS (2007) Sexual dimorphism in oxidant status in spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 292(2):R764-R767